← Back to Search

Prehabilitation Education for Bone Marrow Transplant (IMPROVE-BMT Trial)

N/A
Waitlist Available
Led By Kathryn Schmitz, PhD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 18 months
Awards & highlights

IMPROVE-BMT Trial Summary

This trial will test whether a home-based exercise program or just an educational session can help patients before they start treatment.

Eligible Conditions
  • Bone Marrow Transplant
  • Blood Diseases
  • Physical Activity
  • Prehabilitation

IMPROVE-BMT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of the exercise intervention: more than 50% of the patients approached
Feasibility of the exercise intervention: 50% of included patients actually complete at least one third of the exercise sessions
Safety of the exercise intervention: questionnaire
Secondary outcome measures
Aerobic Capacity: Six Minute Walk Test
Body Pain: Brief Pain Inventory- Short form
Bone Marrow Transplant-related Quality of Life: EORTC QLQ-HDC29
+10 more

IMPROVE-BMT Trial Design

2Treatment groups
Active Control
Group I: Prehabilitation EducationActive Control1 Intervention
Will be offered a prehabilitation and stem cell education class at the Penn State Hershey Cancer Institute.
Group II: Home-Based PrehabilitationActive Control1 Intervention
Will be offered an individual one-on-one appointment for an exercise introduction session with an exercise and cancer specialist and periodical phone calls to support and adapt the exercise program. The exercises should be done home-based for 5 times a week until the time of transplant.

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
492 Previous Clinical Trials
2,798,738 Total Patients Enrolled
Kathryn Schmitz, PhDPrincipal Investigator - Penn State College of Medicine, Hershey
Milton S. Hershey Medical Center
10 Previous Clinical Trials
1,632 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open for this investigation currently?

"Data on clinicaltrials.gov confirms that this medical trial is currently in recruitment mode, starting from June 28th 2019 and having had its last update on March 18th 2022."

Answered by AI

What is the current enrollment status of this clinical research?

"Affirmative. Clinicaltrials.gov documents that this trial is actively seeking candidates since it was first unveiled on June 28th 2019 and most recently updated on March 18th 2022. This experiment needs 84 people to be recruited from a single centre."

Answered by AI

What is the main purpose of this clinical experiment?

"The primary target of this research, which will be monitored over an approximate 18-month stretch, is to have at least 50% of the approached patients accept the exercise intervention. Secondary objectives include assessing Health-related Quality of Life (EORTC QLQ-C30), Physical Function (Timed-Up-and Go Test), and Bone Marrow Transplant related quality of life (EORTC QLQ - HDC29). All these scales range from 0 to 100, with a high score indicating higher response levels for functional scale or global health status/QLo scores but more symptomatology/problems in case"

Answered by AI
~15 spots leftby Apr 2025